Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Tânia A S S Bachega"'
Publikováno v:
PLoS ONE, Vol 7, Iss 9, p e44893 (2012)
BackgroundCAH patients have an increased risk of cardiovascular disease, and it remains unknown if lifelong glucocorticoid (GC) treatment is a contributing factor. In the general population, glucocorticoid receptor gene (NR3C1) polymorphisms are asso
Externí odkaz:
https://doaj.org/article/b170195ebcd84d39a967608b00ea79eb
Publikováno v:
Archives of Endocrinology and Metabolism (2023)
ABSTRACT Congenital adrenal hyperplasia due to 21-hydroxylase deficiency is an autosomal recessive disorder caused by CYP21A2 gene mutations, and its molecular diagnosis is widely used in clinical practice to confirm the hormonal diagnosis. Hence, co
Externí odkaz:
https://doaj.org/article/78fdecf747a74e519fa5fbba15e89dfc
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
Externí odkaz:
https://doaj.org/article/2bbd4e47c5c44e029bd61104a5c16a7f
Autor:
Neil Lawrence, Irina Bacila, Jeremy Dawson, Jillian Bryce, Salma R. Ali, Erica L. T. van den Akker, Tânia A. S. S. Bachega, Federico Baronio, Niels H. Birkebæk, Walter Bonfig, Hedi C. van der Grinten, Eduardo C. Costa, Liat de Vries, Heba Elsedfy, Ayla Güven, Sabine Hannema, Violeta Iotova, Hetty J. van der Kamp, María Clemente, Corina R. Lichiardopol, Tatjana Milenkovic, Uta Neumann, Ana Nordenström, Şukran Poyrazoğlu, Ursina Probst‐Scheidegger, Luisa De Sanctis, Rieko Tadokoro‐Cuccaro, Ajay Thankamony, Ana Vieites, Zehra Yavaş, Syed Faisal Ahmed, Nils Krone
Publikováno v:
Clinical Endocrinology. Wiley-Blackwell
Lawrence, N, Bacila, I, Dawson, J, Bryce, J, Ali, S R, van den Akker, E L T, Bachega, T A S S, Baronio, F, Birkebæk, N H, Bonfig, W, van der Grinten, H C, Costa, E C, de Vries, L, Elsedfy, H, Güven, A, Hannema, S, Iotova, V, van der Kamp, H J, Clemente, M, Lichiardopol, C R, Milenkovic, T, Neumann, U, Nordenström, A, Poyrazoğlu, Ş, Probst-Scheidegger, U, De Sanctis, L, Tadokoro-Cuccaro, R, Thankamony, A, Vieites, A, Yavaş, Z, Faisal Ahmed, S & Krone, N 2022, ' Analysis of therapy monitoring in the International Congenital Adrenal Hyperplasia Registry ', Clinical Endocrinology, vol. 97, no. 5, pp. 551-561 . https://doi.org/10.1111/cen.14796
Clinical Endocrinology, 97(5), 551-561. Wiley-Blackwell Publishing Ltd
Lawrence, N, Bacila, I, Dawson, J, Bryce, J, Ali, S R, van den Akker, E L T, Bachega, T N A S S, Baronio, F, Birkebæk, N H, Bonfig, W, van der Grinten, H C, Costa, E C, de Vries, L, Elsedfy, H, Güven, A, Hannema, S, Iotova, V, van der Kamp, H J, León, M C, Lichiardopol, C R, Milenkovic, T, Neumann, U, Nordenström, A, Poyrazoğlu, Ş, Probst-Scheidegger, U, de Sanctis, L, Tadokoro-Cuccaro, R, Thankamony, A, Vieites, A, Yavaş, Z, Faisal Ahmed, S & Krone, N 2022, ' Analysis of therapy monitoring in the International Congenital Adrenal Hyperplasia Registry ', Clinical Endocrinology, vol. 97, no. 5, pp. 551-561 . https://doi.org/10.1111/cen.14796
Scientia
Clinical Endocrinology, 97(5), 551-561. Wiley-Blackwell
Lawrence, N, Bacila, I, Dawson, J, Bryce, J, Ali, S R, van den Akker, E L T, Bachega, T A S S, Baronio, F, Birkebæk, N H, Bonfig, W, van der Grinten, H C, Costa, E C, de Vries, L, Elsedfy, H, Güven, A, Hannema, S, Iotova, V, van der Kamp, H J, Clemente, M, Lichiardopol, C R, Milenkovic, T, Neumann, U, Nordenström, A, Poyrazoğlu, Ş, Probst-Scheidegger, U, De Sanctis, L, Tadokoro-Cuccaro, R, Thankamony, A, Vieites, A, Yavaş, Z, Faisal Ahmed, S & Krone, N 2022, ' Analysis of therapy monitoring in the International Congenital Adrenal Hyperplasia Registry ', Clinical Endocrinology, vol. 97, no. 5, pp. 551-561 . https://doi.org/10.1111/cen.14796
Clinical Endocrinology, 97(5), 551-561. Wiley-Blackwell Publishing Ltd
Lawrence, N, Bacila, I, Dawson, J, Bryce, J, Ali, S R, van den Akker, E L T, Bachega, T N A S S, Baronio, F, Birkebæk, N H, Bonfig, W, van der Grinten, H C, Costa, E C, de Vries, L, Elsedfy, H, Güven, A, Hannema, S, Iotova, V, van der Kamp, H J, León, M C, Lichiardopol, C R, Milenkovic, T, Neumann, U, Nordenström, A, Poyrazoğlu, Ş, Probst-Scheidegger, U, de Sanctis, L, Tadokoro-Cuccaro, R, Thankamony, A, Vieites, A, Yavaş, Z, Faisal Ahmed, S & Krone, N 2022, ' Analysis of therapy monitoring in the International Congenital Adrenal Hyperplasia Registry ', Clinical Endocrinology, vol. 97, no. 5, pp. 551-561 . https://doi.org/10.1111/cen.14796
Scientia
Clinical Endocrinology, 97(5), 551-561. Wiley-Blackwell
Funder: European Society for Paediatric Endocrinology Research Unit
OBJECTIVE: Congenital adrenal hyperplasia (CAH) requires exogenous steroid replacement. Treatment is commonly monitored by measuring 17-OH progesterone (17OHP) and androstenedio
OBJECTIVE: Congenital adrenal hyperplasia (CAH) requires exogenous steroid replacement. Treatment is commonly monitored by measuring 17-OH progesterone (17OHP) and androstenedio
Autor:
Ricardo P. P. Moreira, Alexander A. L. Jorge, Larissa G. Gomes, Laura C. Kaupert, João Massud Filho, Berenice B. Mendonca, Tânia A. S. S. Bachega
Publikováno v:
Clinics, Vol 66, Iss 8, Pp 1361-1366 (2011)
INTRODUCTION: 21-hydroxylase deficiency is an autosomal recessive disorder that causes glucocorticoid deficiency and increased androgen production. Treatment is based on glucocorticoid replacement; however, interindividual variability in the glucocor
Externí odkaz:
https://doaj.org/article/3ce8e63f566f438699215588f1c13121
Publikováno v:
Clinics, Vol 66, Iss 6, Pp 1041-1044 (2011)
INTRODUCTION: PXR polymorphisms have been implicated in modulating CYP3A4 and PXR expression, potentially accounting for interindividual differences in drug metabolism. The prevalence of PXR polymorphisms varies among ethnic groups and data on the al
Externí odkaz:
https://doaj.org/article/f4783496c7db4a609bc819c74e46ba92
Autor:
Fernanda C Costa, Donaldt L de Sousa, Guiomar Madureira, Patrícia M B R Mathias, Berenice B Mendonca, Mirela C Miranda, Mylena C M Silva, Tânia A S S Bachega
Publikováno v:
Journal of the Endocrine Society. 6:A138-A138
Final height (FH) in congenital adrenal hyperplasia (CAH) patients is frequently under -1.5 SDS in relation to the normal population, even in those with good compliance, chronic androgen exposure or supraphysiological glucocorticoid doses could corro
Autor:
Tânia A S S Bachega, Fernanda C Costa, Guiomar Madureira, Berenice B Mendonca, Mirela C Miranda
Publikováno v:
Journal of the Endocrine Society. 6:A113-A113
Testicular adrenal rest tumors (TARTs) are one of the most frequent comorbidities in males with 21-hydroxylase deficiency (CAH) and different prevalence rates have been reported. TART still present difficult control and frequently lead to infertility
Autor:
Flávia A, Costa-Barbosa, Vânia F, Tonetto-Fernandes, Valdemir M, Carvalho, Odete H, Nakamura, Vivian, Moura, Tânia A S S, Bachega, José G H, Vieira, Claudio E, Kater
Publikováno v:
Clinical endocrinology. 73(6)
Congenital adrenal hyperplasia caused by classic 21-hydroxylase deficiency (21OHD) is an autosomal recessive disorder with a high prevalence of asymptomatic heterozygote carriers (HTZ) in the general population, making case detection desirable by rou
Autor:
Tânia A S S, Bachega, Ana Elisa C, Billerbeck, Erica B, Parente, Sofia H V, Lemos-Marini, Maria Tereza M, Baptista, Maricilda P, Mello, Gil, Guerra, Hilton, Kuperman, Nuvarte, Setian, Durval, Damiani, Natália, Torres, Margaret de, Castro, Berenice B de, Mendonça
Publikováno v:
Arquivos brasileiros de endocrinologia e metabologia. 48(5)
We analyzed the clinical and molecular data of 205 patients with the three different clinical forms of 21-hydroxylase deficiency, in whom the clinical and molecular diagnosis were already defined. The most frequent mutations were I2 splice in the sal